BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $8,615,000 | -20.9% | 170,551 | 0.0% | 2.01% | -25.1% |
| Q1 2022 | $10,895,000 | -47.2% | 170,551 | -11.5% | 2.68% | -46.6% |
| Q4 2021 | $20,634,000 | +13.9% | 192,639 | +9.3% | 5.03% | -12.5% |
| Q3 2021 | $18,113,000 | +46.3% | 176,175 | +25.2% | 5.74% | +35.2% |
| Q2 2021 | $12,382,000 | -4.4% | 140,763 | +5.7% | 4.25% | -16.4% |
| Q1 2021 | $12,947,000 | +86.0% | 133,163 | +114.6% | 5.08% | +14.2% |
| Q4 2020 | $6,960,000 | – | 62,060 | – | 4.45% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 705,159 | $12,728,000 | 12.46% |
| BVF INC/IL | 2,640,251 | $47,657,000 | 11.79% |
| Casdin Capital, LLC | 321,300 | $5,799,000 | 6.66% |
| Opaleye Management Inc. | 220,000 | $3,971,000 | 2.48% |
| PFM Health Sciences, LP | 1,420,511 | $25,640,000 | 0.79% |
| Perceptive Advisors | 404,404 | $7,299,000 | 0.64% |
| Partner Investment Management, L.P. | 18,788 | $339,000 | 0.55% |
| Visium Asset Management, LP | 1,265,025 | $22,834,000 | 0.39% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 661,717 | $11,944,000 | 0.39% |
| Virtus ETF Advisers LLC | 10,484 | $189,000 | 0.26% |